548 Episodes

  1. Addressing the Challenges of Rare Disease Drug Development

    Published: 3/7/2018
  2. Giving Voice to Patients at the FDA

    Published: 2/28/2018
  3. Finding a Rare Friend

    Published: 2/21/2018
  4. Why a Sports Physical May Trigger a Doctor to Think About a Rare Diagnosis

    Published: 2/14/2018
  5. UPenn's Orphan Disease Center Takes a Rare Approach

    Published: 2/7/2018
  6. How Patients Can Accelerate Translational Research in Rare Disease

    Published: 1/31/2018
  7. Notre Dame Center Leverages Commonalities of Rare and Neglected Diseases

    Published: 1/24/2018
  8. GalXC Quest: Dicerna Bets on Its Unqiue Approach to RNAi

    Published: 1/17/2018
  9. Pharnext Takes a Unique Twist on Repurposing Drugs for Rare Diseases

    Published: 1/10/2018
  10. uniQure Seeks to Find Elusive Market Success with Hemophilia B Gene Therapy

    Published: 1/3/2018
  11. Savara Advances Pipeline of Inhaled Therapeutics for Rare Lung Diseases

    Published: 12/27/2017
  12. Why the Microbiome May Provide a Novel Approach to Treating Certain Rare Diseases

    Published: 12/20/2017
  13. FDA Outlines a Collaborative Approach for Pediatric Rare Disease Trials

    Published: 12/13/2017
  14. Why Patient-Centred Outcomes Are Critical to Rare Disease Drug Trials

    Published: 12/6/2017
  15. What the FDA's New Framework Means for Regenerative Therapies

    Published: 11/29/2017
  16. Measuring the Value of Therapies for Ultra-Rare Diseases

    Published: 11/22/2017
  17. Lessons from Pitching Venture Capitalists

    Published: 11/15/2017
  18. Health Canada Scraps Plans for Orphan Drug Framework

    Published: 11/8/2017
  19. New Investment Boosts Rare Disease Drug Accelerator

    Published: 11/1/2017
  20. Understanding Rare Disease Caregiver Needs

    Published: 10/25/2017

20 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.